Insider Stratton John G Adds 2,000 Shares to Abbott, Signaling Quiet Confidence Amid Mild Sell‑off.
Stratton John G’s recent 2,000‑share purchase of Abbott Laboratories, amid modest insider buying, signals long‑term confidence in the diagnostics‑driven growth strategy.
3 minutes to read